X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank20
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-86.88M
↓ 40% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-62.14M
Historical baseline
PeriodValueYoY Change
TTM$-86.88M-138.7%
2024$-36.40M+66.1%
2023$-107.52M-22.8%
2022$-87.57M-2.9%
2021$-85.11M-42.1%
2020$-59.87M-15.8%
2019$-51.70M-12.7%
2018$-45.88M-27.0%
2017$-36.13M-48.4%
2016$-24.35M-